194 related articles for article (PubMed ID: 7446530)
21. Detection of Tay-Sachs disease carriers among individuals with thermolabile hexosaminidase B.
Peleg L; Goldman B
Eur J Clin Chem Clin Biochem; 1994 Feb; 32(2):65-9. PubMed ID: 8003579
[TBL] [Abstract][Full Text] [Related]
22. The biochemical genetics of the hexosaminidase system in man.
Beutler E
Am J Hum Genet; 1979 Mar; 31(2):95-105. PubMed ID: 377957
[TBL] [Abstract][Full Text] [Related]
23. The biochemical basis of gangliosidoses.
Sandhoff K; Conzelmann E
Neuropediatrics; 1984 Sep; 15 Suppl():85-92. PubMed ID: 6242704
[No Abstract] [Full Text] [Related]
24. Nomenclature of GM2-gangliosidoses.
Nørby S
Clin Genet; 1980 May; 17(5):320-2. PubMed ID: 7192191
[TBL] [Abstract][Full Text] [Related]
25. Sandhoff disease: a prevalent form of infantile GM2 gangliosidosis in Lebanon.
Der Kaloustian VM; Khoury MJ; Hallal R; Idriss ZH; Deeb ME; Wakid NW; Haddad FS
Am J Hum Genet; 1981 Jan; 33(1):85-9. PubMed ID: 7468596
[TBL] [Abstract][Full Text] [Related]
26. Alpha-locus hexosaminidase genetic compound with juvenile gangliosidosis phenotype: clinical, genetic, and biochemical studies.
Johnson WG; Cohen CS; Miranda AF; Waran SP; Chutorian AM
Am J Hum Genet; 1980 Jul; 32(4):508-18. PubMed ID: 6772023
[TBL] [Abstract][Full Text] [Related]
27. A pseudodeficiency allele common in non-Jewish Tay-Sachs carriers: implications for carrier screening.
Triggs-Raine BL; Mules EH; Kaback MM; Lim-Steele JS; Dowling CE; Akerman BR; Natowicz MR; Grebner EE; Navon R; Welch JP
Am J Hum Genet; 1992 Oct; 51(4):793-801. PubMed ID: 1384323
[TBL] [Abstract][Full Text] [Related]
28. Natural history and inherited disorders of a lysosomal enzyme, beta-hexosaminidase.
Neufeld EF
J Biol Chem; 1989 Jul; 264(19):10927-30. PubMed ID: 2525553
[No Abstract] [Full Text] [Related]
29. A novel gene editing system to treat both Tay-Sachs and Sandhoff diseases.
Ou L; Przybilla MJ; Tăbăran AF; Overn P; O'Sullivan MG; Jiang X; Sidhu R; Kell PJ; Ory DS; Whitley CB
Gene Ther; 2020 May; 27(5):226-236. PubMed ID: 31896760
[TBL] [Abstract][Full Text] [Related]
30. Juvenile Sandhoff Disease: complementation tests with Sandhoff and Tay-Sachs disease using polyethylene glycol-induced cell fusion.
Wood S
Hum Genet; 1978 Apr; 41(3):325-9. PubMed ID: 417993
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus transformed lymphoid cell lines as a new model system in culture for the study of GM2-gangliosidoses: Tay-Sachs and Sandhoff diseases.
Maret A; Salvayre R; Negre A; Bes JC; Douste-Blazy L
Biol Cell; 1985; 53(3):293-6. PubMed ID: 2990625
[TBL] [Abstract][Full Text] [Related]
32. Evidence for a hybrid hexosaminidase isoenzyme in heterozygotes for Sandhoff disease.
Lowden JA
Am J Hum Genet; 1979 May; 31(3):281-9. PubMed ID: 463876
[TBL] [Abstract][Full Text] [Related]
33. [Gangliosidosis GM2 type 2 (Sandhoff disease)].
Sánchez-Corona J; Vaca G; González-Flores SA; Villar V; Solé MT; Barajas LO; Velázquez R; Valdez-Luviano J; Cantú JM
Rev Invest Clin; 1985; 37(1):43-7. PubMed ID: 4001618
[No Abstract] [Full Text] [Related]
34. The frequency of Tay-Sachs disease causing mutations in the Brazilian Jewish population justifies a carrier screening program.
Rozenberg R; Pereira Lda V
Sao Paulo Med J; 2001 Jul; 119(4):146-9. PubMed ID: 11500789
[TBL] [Abstract][Full Text] [Related]
35. The mutation mechanism causing juvenile-onset Tay-Sachs disease among Lebanese.
Hechtman P; Boulay B; Bayleran J; Andermann E
Clin Genet; 1989 May; 35(5):364-75. PubMed ID: 2527097
[TBL] [Abstract][Full Text] [Related]
36. Novel mutations and DNA-based screening in non-Jewish carriers of Tay-Sachs disease.
Akerman BR; Natowicz MR; Kaback MM; Loyer M; Campeau E; Gravel RA
Am J Hum Genet; 1997 May; 60(5):1099-106. PubMed ID: 9150157
[TBL] [Abstract][Full Text] [Related]
37. Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases.
Phaneuf D; Wakamatsu N; Huang JQ; Borowski A; Peterson AC; Fortunato SR; Ritter G; Igdoura SA; Morales CR; Benoit G; Akerman BR; Leclerc D; Hanai N; Marth JD; Trasler JM; Gravel RA
Hum Mol Genet; 1996 Jan; 5(1):1-14. PubMed ID: 8789434
[TBL] [Abstract][Full Text] [Related]
38. Patient and caregiver perspectives on burden of disease manifestations in late-onset Tay-Sachs and Sandhoff diseases.
Lyn N; Pulikottil-Jacob R; Rochmann C; Krupnick R; Gwaltney C; Stephens N; Kissell J; Cox GF; Fischer T; Hamed A
Orphanet J Rare Dis; 2020 Apr; 15(1):92. PubMed ID: 32295606
[TBL] [Abstract][Full Text] [Related]
39. Identification of Sandhoff disease in a Thai family: clinical and biochemical characterization.
Sakpichaisakul K; Taeranawich P; Nitiapinyasakul A; Sirisopikun T
J Med Assoc Thai; 2010 Sep; 93(9):1088-92. PubMed ID: 20873083
[TBL] [Abstract][Full Text] [Related]
40. Characterization of polypeptides serologically and structurally related to hexosaminidase in cultured fibroblasts.
Tsui F; Mahuran DJ; Lowden JA; Mosmann T; Gravel RA
J Clin Invest; 1983 Apr; 71(4):965-73. PubMed ID: 6833496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]